Money · Lobbying reports · 119th Congress
S. 1862
12 saved lobbying reports name S. 1862.
12 reports
Confirmed from the official recordSenate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.
Lobbying Disclosure Act reports, LDA.gov. This copy was read November 22, 2026 at 12:39 PM Eastern.
Reports that name this bill
The amount is what the report gives for the whole quarter: everything the registrant did for that client, all issues together. A linked name opens that organization’s page on this site.
| Registrant | Client | Amount for the whole quarter | Quarter | Filed | Report |
|---|---|---|---|---|---|
| EMD SERONO, INC. | EMD SERONO INC | $730,000.00reported as expenses | July to September 2026 | Open the report | |
| AVENUE SOLUTIONS | JAZZ PHARMACEUTICALS, INC. | $50,000.00reported as income | July to September 2026 | Open the report | |
| ASTRAZENECA PHARMACEUTICALS LP | ASTRAZENECA PHARMACEUTICALS LP | $810,000.00reported as expenses | July to September 2026 | Open the report | |
| INCYTE CORPORATION | INCYTE CORPORATION | $380,000.00reported as expenses | July to September 2026 | Open the report | |
| BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC | BOEHRINGER INGELHEIM USA CORPORATION | $1,020,000.00reported as expenses | July to September 2026 | Open the report | |
| ACADIA PHARMACEUTICALS | ACADIA PHARMACEUTICALS | $440,000.00reported as expenses | July to September 2026 | Open the report | |
| TRAVERE THERAPEUTICS | TRAVERE THERAPEUTICS | $100,000.00reported as expenses | July to September 2026 | Open the report | |
| TODD STRATEGY GROUP | ASTRAZENECA PHARMACEUTICALS LP | $80,000.00reported as income | July to September 2026 | Open the report | |
| TODD STRATEGY GROUP | EMD SERONO INC. | $50,000.00reported as income | July to September 2026 | Open the report | |
| LMH STRATEGIC SOLUTIONS | IONIS PHARMACEUTICALS, INC. | $30,000.00reported as income | July to September 2026 | Open the report | |
| LMH STRATEGIC SOLUTIONS | ALNYLAM PHARMACEUTICALS, INC. | $50,000.00reported as income | July to September 2026 | Open the report | |
| LUNDBECK LLC | LUNDBECK LLC | $130,000.00reported as expenses | July to September 2026 | Open the report |